These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7389036)

  • 21. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizer. Role of binding of both unreduced and radiation-reduced forms to DNA, in vitro.
    Silver AR; O'Neill P; Jenkins TC
    Biochem Pharmacol; 1985 Oct; 34(19):3537-42. PubMed ID: 3902026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitroreduction of 4-nitropyrene is primarily responsible for DNA adduct formation in the mammary gland of female CD rats.
    Chae YH; Ji BY; Lin JM; Fu PP; Cho BP; El-Bayoumy K
    Chem Res Toxicol; 1999 Feb; 12(2):180-6. PubMed ID: 10027796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative distribution of misonidazole and its amine metabolite in female Swiss Webster mice.
    Born JL; Hadley WM
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1157-61. PubMed ID: 3997598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of binding process of chlorpromazine to bovine serum albumin by means of passive and active experiments.
    Rukhadze MD; Bezarashvili GS; Sidamonidze NS; Tsagareli SK
    Biomed Chromatogr; 2001 Oct; 15(6):365-73. PubMed ID: 11559920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hepatic microsomal enzyme inducers on the metabolism of misonidazole in rats.
    Shoemaker D; Upton D; Strong J
    Cancer Treat Rep; 1980; 64(2-3):275-7. PubMed ID: 7407761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benznidazole: nitroreduction and inhibition of cytochrome P-450 in chemosensitization of tumour response to cytotoxic drugs.
    Workman P; Walton MI; Lee FY
    Biochem Pharmacol; 1986 Jan; 35(1):117-9. PubMed ID: 3940522
    [No Abstract]   [Full Text] [Related]  

  • 28. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers.
    Koch CJ; Giandomenico AR; Iyengar CW
    Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of globular proteins to DNA from surface tension measurement.
    Mitra A; Chattoraj DK; Chakraborty P
    Indian J Biochem Biophys; 2001 Oct; 38(5):313-20. PubMed ID: 11886079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of hypoxia on the metabolism and excretion of misonidazole by the isolated perfused rat liver--a model system.
    Smith BR; Born JL; Garcia DJ
    Biochem Pharmacol; 1983 May; 32(10):1609-12. PubMed ID: 6860347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
    Chin JB; Rauth AM
    Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative misonidazole metabolism in anaerobic bacteria and hypoxic Chinese hamster lung fibroblast (V-79-473) cells.
    Koch RL; Rose C; Rich TA; Goldman P
    Biochem Pharmacol; 1982 Feb; 31(3):411-4. PubMed ID: 7073768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No significant effect of cimetidine on the pharmacokinetics of misonidazole in man.
    Begg EJ; Williams KM; Wade DN; O'Shea KF
    Br J Clin Pharmacol; 1983 May; 15(5):575-6. PubMed ID: 6860535
    [No Abstract]   [Full Text] [Related]  

  • 34. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules.
    Raleigh JA; Koch CJ
    Biochem Pharmacol; 1990 Dec; 40(11):2457-64. PubMed ID: 2176499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy.
    Bahnemann D; Basaga H; Dunlop JR; Searle AJ; Willson RL
    Br J Cancer Suppl; 1978 Jun; 3():16-9. PubMed ID: 277218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenytoin sodium-induced alterations in the pharmacokinetics of misonidazole in the dog.
    White RA; Workman P
    Cancer Treat Rep; 1980; 64(2-3):360-1. PubMed ID: 7190871
    [No Abstract]   [Full Text] [Related]  

  • 37. Circadian changes in the elimination of misonidazole in mouse.
    Labat C; Malmary MF; Casanovas AM; Patau JP; Oustrin J
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):331-4. PubMed ID: 6658193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of DNA strand breaks by reduced nitroimidazoles. Implications for DNA base damage.
    Silver AR; McNeil SS; O'Neill P; Jenkins TC; Ahmed I
    Biochem Pharmacol; 1986 Nov; 35(22):3923-8. PubMed ID: 3778516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between misonidazole cytotoxicity and base composition of DNA.
    Rowley DA; Knight RC; Skolimowski IM; Edwards DI
    Biochem Pharmacol; 1980 Aug; 29(15):2095-8. PubMed ID: 7190826
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenytoin-misonidazole: possible metabolic interaction.
    Gangji D; Schwade JG; Strong JM
    Cancer Treat Rep; 1980 Jan; 64(1):155-6. PubMed ID: 7379050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.